Growth Metrics

Neogenomics (NEO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Neogenomics (NEO) over the last 13 years, with Q3 2025 value amounting to $20.8 million.

  • Neogenomics' Non-Current Deferred Tax Liability fell 845.37% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.8 million, marking a year-over-year decrease of 845.37%. This contributed to the annual value of $21.5 million for FY2024, which is 8182.83% down from last year.
  • As of Q3 2025, Neogenomics' Non-Current Deferred Tax Liability stood at $20.8 million, which was down 845.37% from $20.0 million recorded in Q2 2025.
  • Neogenomics' Non-Current Deferred Tax Liability's 5-year high stood at $143.1 million during Q4 2021, with a 5-year trough of $1.7 million in Q1 2021.
  • Its 5-year average for Non-Current Deferred Tax Liability is $46.8 million, with a median of $28.8 million in 2023.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first plummeted by 8935.09% in 2021, then soared by 286496.56% in 2022.
  • Over the past 5 years, Neogenomics' Non-Current Deferred Tax Liability (Quarter) stood at $143.1 million in 2021, then dropped by 9.45% to $129.6 million in 2022, then dropped by 8.63% to $118.4 million in 2023, then plummeted by 81.83% to $21.5 million in 2024, then decreased by 3.09% to $20.8 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $20.8 million for Q3 2025, versus $20.0 million for Q2 2025 and $21.0 million for Q1 2025.